BACKGROUND: Measurements of GFR may be performed with a slope/intercept method (S/I), using only two blood samples taken in strictly defined time points. The aim of the study was to modify this method in order to extend time intervals suitable for
Background
Renal clearance is a measure of renal efficiency in elimination of metabolites from blood. For this reason measurement of renal clearance is necessary in a clinical practice. Clearance of blood plasma from metabolites takes place in two parts of a nephron, as a result of two different processes; therefore, it is possible to determine clearance values specific for those processes: glomerular filtration rate (GFR), tubular extraction rate (TER) and also effective renal plasma flow (ERPF) combining both mentioned above renal functions.
Glomerular filtration rate is considered the best measure of renal function among types of clearance specified above, in both healthy and sick people. However, measurement of GFR in clinical practice is troublesome. For this reason renal function is usually assessed from serum creatinine level. In order to make this troublesome measurement of GFR easier, several equations were developed, allowing the assessment of GFR from serum creatinine level, patient age, sex and body size [1] [2] [3] [4] [5] [6] [7] . Although in general those equations can be used to assess renal function in clinical practice, one should keep in mind that they were developed after assumption of several simplifications and therefore calculated values may be burdened with a relatively large error. Moreover, serum creatinine level depends not only on filtration rate, but also some other factors
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Original like protein consumption [8] . For these reasons, precision and accuracy of GFR assessed from serum creatinine level are poor.
Substances labeled with radionuclides proved to be highly useful in measurements of clearances. They allowed the assessment of renal clearance after a single injection of a radiopharmaceutical, without measurements of activity secreted with urine [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
First methods applied for renal clearance assessments were based on a two-compartment open model of distribution and elimination of endogenous creatinine, developed by Sapirstein et al. [9] , which was further adapted for radiopharmaceutical applications [10] [11] [12] [13] [14] . Those methods are considered "gold standard" and are still in use. They apply a formula which takes into account activity of administered radiopharmaceutical and also its concentration in blood plasma measured in several [9] [10] [11] [12] blood samples taken from 5 minutes to 180 minutes (sometimes even longer) after injection. Those methods are referred to as multi-sample techniques.
In studies aiming at facilitation of measurement of GFR several authors reduced numbers of blood samples. They mostly applied a method named slope/intercept (S/I), which requires two or three blood samples [12] [13] [14] . This simplification is with no doubt beneficial, but, on the other hand, authors of those procedures recommend taking blood samples in strictly determined time points after injection. In everyday practice of nuclear medicine departments such requirements not always can be met. Also a long stay in a healthcare facility, sometimes even exceeding 5 hours, can be cumbersome for a patient. Those facts encouraged us to work on a modification of a two-sample method introduced by Russel et al. [15] in order to extend time intervals suitable for blood sampling with possible shortening of patient's stay in a nuclear medicine department. Moreover, introduction of targeted radionuclide therapy into clinical practice, where kidneys are often critical organs and need monitoring [16, 17] increases requirement for relatively simple, quick and reliable method for measurement of renal function.
The aim of the work was to modify a two-sample method used for measurement of GFR, introduced by Russel et al. [15] . This objective was achieved by the following partial goals: 
Material and methods

Theoretical basis
GFR calculations are based on a formula derived from a two-compartmental open model of a distribution and excretion of a substance: , is much slower; this is why it is referred to as a slow phase. Calculations of function parameters for a given patient are based on measurements of blood plasma samples taken several times after injection, at early and late stage of a study, fitting of a mathematical formula of a function (2) to measurements; parameters calculated in this way, together with administered activity, can be used in formula (1) for calculation of GFR.
A quick phase vanishes rapidly so a contribution of a low phase to a denominator of formula (1) is by far higher than of the quick one. This is why some authors recommend calculation of renal clearence based on a slow phase only [12] [13] [14] [15] 18] . They use the following formula for this purpose:
In order to calculate parameters A 2 and b 2 only two blood samples are necessary, taken in a late phase of a study when contribution of a quick phase is negligible. Cl symbol applies to a clearance value determined with an S/I method from two blood samples.
From a comparison of equations (1) and (3) it is clear that Cl value is larger than GFR, so Cl should be corrected in order to be closer to GFR. Such corrections were proposed by Brøchner-Mortenson [17] and Hagstam et al. [18] who applied a quadratic correction according to an equation:
Correction coefficients f and g were determined empirically. So for a first blood sample taken 90 or 120 minutes, and the second one taken 240 minutes after injection, Brøchner-Mortenson [17] , Hangston et al. [18] and Tepe et al. [19] calculated the following values for g and f coefficients, respectively: 0.990778 and -0.001218 when GFR was measured in adults and 1.01 and -0.0017 when it concerned children.
However, Russell et al. [15] proposed exponential correction according to an equation:
with value of correction parameter 0 < a < 1, which is also determined empirically. For blood samples taken in T 1 ≈60 min and T 2 ≈180 min the authors obtained a =0. 979 .
Values of exponent a as well as f and g coefficients may be different for other times of blood sampling because, although a quick phase of a curve is declining fast, it differs between particular time points and its values can affect correction parameters. So, in order to allow for blood sampling in time intervals instead of time points, correction parameters should vary with time.
We applied in our work modification proposed by Russell et al. [15] .
The study was approved by the Medical University Bioethics Committee.
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Uncertainties DGFR T1\2 , DGFR p and DGFR s were assessed from differential of formula (6) taking into account also formula (3), assuming that time measurements errors did not exceed 10 s, pipetting error was equal to 2%, and uncertainty of radioactive sample measurement was not greater than 1%. Own experience of the authors of this work points out that uncertainties of those measurements are smaller in practice. However, it is better to overestimate potential errors than to neglect them. 
Results
Figure1 presents an illustrative relationship between
When Cl k, l values were already calculated for respective GFR values (511 Cl k, l values for every GFR), exponential formula (5) was used to determine a functional relationship between these values. Fitting of equations was based on determination of exponent α in such a way that a sum of squares was minimal. Sum of squares of remainders allows determining a standard error of estimate (SEE) of fitting to measured values. These calculations were made using Statistica software.
Selection of time intervals
Time intervals for which a standard error of the estimate (SEE) was not larger than 3.6 mL/min were selected. This criterion is in agreement with a recommendation published by Brøchner-Mortenson [17] .
A set of SEE values for which the above criterion is met was used to create a formula presenting relationship between SEE and selected values of T 1 and T 2 (time points of first and second blood sampling, respectively) -SEE (T 1 , T 2 ). This function had a form of a polynomial of a degree for which a coefficient of determination was not lower than 0.996.
Assessment of uncertainty of modified GFR measurement
Uncertainty DGFR of modified GFR measurements was estimated using law of error superposition, taking into account prediction error S pr , determined by SEE (see Appendix) and errors made during study performance resulting from uncertainties of blood sampling times DGFR T1 and DGFR T2 , pipetting DGFR p and a stochasticity of radioactive decay DGFR s , so: 
In Table 2 values of exponent a calculated for ends of time intervals are presented. It can be seen that a difference between maximal and minimal values of this exponent does not exceed 0.0017. This is why a constant value of exponent a equal to its mean value of 0.9812 was accepted instead of varying it with sampling times. SEE values given in Table 1 and calculated from formula (7) make up the smallest width of so called error corridor (referred to as prediction error) achieved for mean abscissa and ordinate values. For minimal and maximal values of GFR a width of an error corridor (prediction error) increases only by 0.1%, which equals to 0.0003 mL/min. For this reason a constant prediction error for a whole range of calculated clearence values equal to SEE was accepted while assessing the uncertainty of modified calculations of GFR results. Figure 3 illustrates how uncertainty of GFR measurement changes with its value, when blood sampling is made in 90 minute and 150 minute after injection. It can be seen that a whole uncertainty is determined mostly by the prediction error and pipetting error and to a much lesser extent by timing errors. Figure 4 presents how a whole relative uncertainty (precision) of GFR measurement changes, when blood sampling is made at least (90 and 150 minutes) and most (60 and 180) appropriate times after injection. Differences between those values are considerable for low GFR values -from 5 mL/min to 15 mL/min and are equal to 11% and 6%, respectively. Then, above 15 mL/min these differences in precision decline to 2.5% for GFR ≈20 mL/min, to 2% for GFR ≈30 mL/min, to 1.5% for GFR ≈45 mL/min and to 0.25% for GFR ≈180 mL/min. It corresponds to differences in absolute uncertainties at least and most appropriate measurement conditions from about 1 mL/min to 0.5 mL/min. For other T 1 , T 2 pairs taken from earlier selected time intervals the whole uncertainties are comparable and do not exceed mentioned above values.
Discussion
Brøchner-Mortensen as well as other authors proved that it is possible to measure GFR after taking only two blood samples 3-5 hours after injection of 51 Cr-EDTA or 99m Tc-DTPA [15, [18] [19] [20] . Analyses presented in this work confirm this possibility, also when blood samples are taken in other time points than those recommended by the authors mentioned above, preserving equal value of a standard error of estimate (SEE), namely 3.6 mL/min, Original as recommended by Brøchner-Mortensen et al. [17] . This criterion is met when a first blood sample is taken in time 60 min ≤ T 1 ≤ 90 min, and the second one at 150 min ≤ T 2 ≤ 180 minutes after injection. Calculated values of exponent a vary from 0.98052 for a shortest time interval between blood samplings (T 1 = 90 min, T 2 = 150 min) to 0.98228 for blood samples taken 60 and 180 minutes after injection. Those values, although slightly higher, are in good agreement with a value 0.979 presented in a publication by Russel et al. [15] .
Minor, smaller than 0.2%, variability of exponent a in determined time intervals allows using its mean value, namely 0.9812, for time pairs T 1 , T 2 instead of calculating its exact value. Chantler et al. [11] proceed in the same way, even when blood samples are taken in times points different from those recommended by Russell et al. [15] . However, a mean value used instead of a calculated one for a given time pair T 1 and T 2 changes accuracy of a resultant value, especially when blood samples are taken at ends of time intervals. Our analysis proved that accuracy of calculated values in case of most unfavorable times T 1 and T 2 will not exceed 1 mL/min when GFR ≈180 mL/min. This inaccuracy decreases with decline of GFR values and reaches 0.02 mL/min for GFR ≈10 mL/min. Such a small change of accuracy does not affect interpretation of calculated GFR values. On this basis the modified method for GFR calculation may be considered sufficiently accurate.
In every method used for measurement of a given quantity an uncertainty of its results should be also assessed. This task was also performed in this work. As mentioned earlier, a model of a relation between modified and full measurement of GFR, referred to as a prediction error determined by SEE, as well as manual activities contribute to uncertainty of results.
Obtained results point out that a prediction error determined by SEE for optimal time points of blood sampling is equal 2.9 mL/min and for less favorable times it reaches 3.5 mL/min for middle values of GFR. Moreover, for extremely low and high GFR values, 10 mL/min and 180 mL/min, respectively, a prediction error increases only by 0.001 mL/min, for optimal as well less favorable times of blood sampling. For this reason a prediction error can be considered constant for the whole range of analyzed GFR values, its value depending only on blood sampling times. This error cannot be completely eliminated, only minimized. This is why possibly long time laps between blood samplings are recommended.
Manual activities are another source of a significant error. Analysis of uncertainties revealed a relatively high contribution of pipetting in this error. This contribution grows with GFR value and for high clearance values it surpasses a prediction error. Relations presented in Figure 4 were calculated for 2% pipetting precision, which is a realistic value of this kind of error.
As can be seen in Figure 3 , errors in time measurements affect overall uncertainty of measurements to a lesser extent. Accepted uncertainty of time measurement was 10 seconds, an excessive value for vast majority of cases.
After considering all partial uncertainties and adding them according to a law of error superposition a relation between total absolute uncertainty of GFR measurement and its value was obtained (Fig. 3) . As can be seen, uncertainty of absolute measurement increases with its value, from about 4 mL/min for GFR equal to 5-10 mL/min to about 8 mL/min for GFR = 180 mL/min, when blood samples are taken 90 and 150 minutes after injection. When blood sampling is made at more favorable time points, like 60 minutes and 180 minutes after injection, a curve presenting uncertainty of measurement is located about 0.5 mL/min lower. So, for time intervals selected earlier uncertainties of measurement are almost equal.
Precision is a metrological characteristic of a measurement procedure. In this case a relative measurement uncertainty may be accepted as a measurement precision. Figure 4 presents its relation to GFR values for optimal and most unfavorable time points of blood sampling. When samples are taken at optimal time points (60 and 180 minutes), a relative uncertainty of measurement falls abruptly from 55% for GFR = 5 mL/min to 10% for GFR = 30 mL/min and then mildly to about 5% for GFR = 180 mL/min (Fig. 4, solid line) . When blood samples are taken at least favorable time points (90 and 150 minutes) a shape of a curve is similar but its values are higher by about 10%. For higher GFR values differences between uncertainties decrease and for GFR = 180 mL/min both curves overlap. All in all, a precision of GFR measurement with a modified method is satisfactory for blood sampling at all time points within earlier determined time intervals. Moreover, for GFR > 40 mL/min a measurement precision is comparable with precision of a multi-sample method [21] .
It should be also mentioned that results of GFR measurement, in order to be comparable among patients, should be normalized to patient body surface, which can be calculated from the Haycock [22] 
